Should the FDA consider cost effectiveness when approving new drug applications?(Pro & Con): An article from: Family Practice News

This digital document is an article from Family Practice News, published by International Medical News Group on August 15, 2004. The length of the article is 753 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Should the FDA consider cost effectiveness when approving new drug applications?(Pro & Con)
Author: Mark Hayman
Publication:Family Practice News (Magazine/Journal)
Date: August 15, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 16 Page: 11(1)

Distributed by Thomson Gale